These results indicate that SOX9 in prostate basal cells supports the development and maintenance of the luminal epithelium and that a subset of prostate cancer cells may escape basal cell requirements through SOX9 expression.” An increased value of SOX9 expression in advanced prostate cancer has been associated to tumor progression and the epithelial-mesenchymal transition [81]. This evidence concerns the gene SOX9 and prostate carcinoma.